A Case of Peritoneal Tuberculosis with Poncet's Disease in a Patient Treated with Infliximab
Journal of Rheumatic Diseases
; : 55-59, 2011.
Article
en Ko
| WPRIM
| ID: wpr-104645
Biblioteca responsable:
WPRO
ABSTRACT
Infliximab is a chimeric mouse/human monoclonal antibody against tumor necrosis factor-alpha (TNF-alpha) that is used worldwide to treat rheumatic disease. However, the reactivation of tuberculosis, including extrapulmonary menifestation, is a severe side effect of anti-TNF-alpha treatment. Mycobacterium tubercluosis causes two forms of joint involvement, TB arthritis and Poncet's disease. Poncet's disease is a rare aseptic form of arthritis, known as reactive arthritis in tuberculosis. We encountered a case of tuberculous peritonitis with Poncet's disease in a 38-yearold man with a history of ankylosing spondylitis that was treated with infliximab. We report this case with a review of the literature.
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Artritis
/
Espondilitis Anquilosante
/
Tuberculosis
/
Peritonitis Tuberculosa
/
Enfermedades Reumáticas
/
Factor de Necrosis Tumoral alfa
/
Artritis Reactiva
/
Infliximab
/
Articulaciones
/
Anticuerpos Monoclonales
Límite:
Humans
Idioma:
Ko
Revista:
Journal of Rheumatic Diseases
Año:
2011
Tipo del documento:
Article